Gurjar, Rohan
Dickinson, Laura http://orcid.org/0000-0001-5557-9396
Carr, Daniel
Stöhr, Wolfgang
Bonora, Stefano
Owen, Andrew http://orcid.org/0000-0002-9819-7651
D’Avolio, Antonio
Cursley, Adam
De Castro, Nathalie
Fätkenheuer, Gerd
Vandekerckhove, Linos
Di Perri, Giovanni
Pozniak, Anton
Schwimmer, Christine
Raffi, François
Boffito, Marta
,
Article History
Received: 8 December 2021
Revised: 13 September 2022
Accepted: 29 September 2022
First Online: 20 October 2022
Competing interests
: SB and GDP have received research grants, travel grants, and consultancy fees from Abbvie, Boehringer-Inghelheim, Bristol-Myers Squibb, Merck Sharp & Dohme, Gilead Sciences, Janssen-Cilag and ViiV Healthcare. AO has received research funding income from ViiV Healthcare, Merck, and Janssen, as well as consultancies from ViiV Healthcare and Merck. He is also a co-inventor of patents relating to the use of nanotechnology in drug delivery, and is a director of Tandem Nano Ltd. FR has received advisory or invited speaker honoraria and have received research grants from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck Laboratories, Merck Sharp & Dohme, Tobira and ViiV Healthcare. NDC has received one research grant from Gilead. AP has received research funding income from ViiV Healthcare, Merck, Gilead and Janssen, was NEAT co-chair and has participated in advisory boards and symposia for ViiV Healthcare, Gilead, Janssen and Merck. CS is involved in IMI-2 funded Ebovac2 and Ebovac3 consortia on Ebola vaccine development, in which Janssen is the industrial partner, and in a publicly funded and sponsored Ebola vaccine trial (Prevac trial) for which Janssen and Merck provide the investigational products (vaccines). MB has received travel and research grants from and has been advisor for Janssen, Roche, ViiV, Bristol-Myers Squibb, Merck Sharp & Dohme, Gilead Sciences, Mylan, Cipla and Teva. All other authors have none to declare.